Orchid granted Certificate of Suitability for Cefadroxil Monohydrate

30 Mar 2004

1

Chennai: Orchid Chemicals & Pharmaceuticals Ltd. (Orchid), the Chennai-based pharma major today announced that it has been granted the Certificate of Suitability (CoS) by the European Directorate for the Quality of Medicines (EDQM) for its API product Cefadroxil Monohydrate. This is the 7th CoS that has been granted to Orchid.

"Europe is a key market in our overall regulated market strategy. We are focusing on a basket of products including premium high-value products as well as established ones. We now have 7 Certificates of Suitability (CoS) granted and we are confident of enlarging our business base in Europe during the coming quarters", said Mr K Raghavendra Rao, Managing Director, Orchid Chemicals & Pharmaceuticals Ltd.

 

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more